Stock screenerAll disclosures →
EDGAR →
CCCC
Conviction 85HealthcareScan · Mon, Aug 10, 2026CCCC$3.61-3.22%
ResistanceSupportVol 14Vol MA14 2.6M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price3.61
Change-3.22%
Gap+0.00%
Rel volume1.95×
Avg volume2.81M
Avg $ vol10.2M
SMA 203.63
SMA 503.92
SMA 2002.90
Price vs 50-7.94%
Price vs 200+24.65%
MA stackmixed
50/200 cross—
Supertrenddown · 4.23
RSI (14)46
MACD hist0.01
MACD crossbull · 2d
Stoch %K / %D42 / 51
ADX (14)15
+DI / −DI16 / 18
RSI divergence—
MACD divergence—
ATR %+6.54%
ADR %5.79%
52w high4.67
52w low1.71
From 52w high-22.70%
Above 52w low+111.11%
New 52w highNo
SqueezeOn · 4d
Bollinger width12.24%
%B0.46
Donchian pos40.98%
Donchian high3.97
Donchian low3.36
AVWAP (52w high)3.89
vs AVWAP high-7.25%
AVWAP (52w low)3.40
vs AVWAP low+6.17%
OBV trendDown
Chaikin MF (20)-0.05
Today vs 20d1.95×
Avg vol (14d)2.6M
Avg vol (20d)2.81M
Avg $ vol (20d)10.2M
Market cap399.15M
RS 3m (vs SPY)+19.47%
RS 6m (vs SPY)+104.01%
RS line new highNo
Trend template7/8
Technical rank62.6
1 week+3.14%
1 month-11.08%
3 months+22.37%
6 months+98.35%
1 year+39.92%
YTD+87.05%
P/E-3.80
P/B1.70
P/S11.10
P/FCF-4.02
EPS-1.27
Div yield—
ROE-44.82%
ROA-31.93%
Debt/Eq0.00
Current9.00
EV/EBITDA—
Gross margin—
Net margin-292.08%
Rev growth1.02%
EPS growth0.31%
Price target8.50
Target upside135.46%
Analyst ratingBuy
Institutional89.72%
Ent. value337.87M
Revenue6.15M
Net income-25.13M
Gross profit—
Free cash flow-99.3M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out110.57M
Employees104
ListedFri, Oct 2, 2020
Free float75.13M
Float %77.5%
Short interest23.82M
Days to cover6.7d
Short volume42.4%
Squeeze score81 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.20 vs −$0.21
Last surprise+4.8% beat
Setup gradeA+
Conviction85 / 100
Pattern quality—
Tech rank62.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.83
Support3.38
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CCCC
No recent disclosed trades by Congress in CCCC. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CCCC · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
REYNO LEONARD Chief Medical Officer · Common Stock · 2026-07-10 | Exercise | 15.32K | — | 2026-07-10 | 2026-07-13 |
REYNO LEONARD Chief Medical Officer · Common Stock · 2026-07-10 | Tax | 7.4K | $30K | 2026-07-10 | 2026-07-13 |
GROGAN DONNA ROY Director · Stock Option (Right to Buy) · 2026-06-24 | Grant | 62K | — | 2026-06-24 | 2026-06-26 |
Fawell Stephen Director · Stock Option (Right to Buy) · 2026-06-24 | Grant | 62K | — | 2026-06-24 | 2026-06-26 |
Cooper Ronald Harold Wilfred Director · Stock Option (Right to Buy) · 2026-06-24 | Grant | 62K | — | 2026-06-24 | 2026-06-26 |
Hoerter Steven L. Director · Stock Option (Right to Buy) · 2026-06-24 | Grant | 62K | — | 2026-06-24 | 2026-06-26 |
Hughes Owen Director · Stock Option (Right to Buy) · 2026-06-24 | Grant | 62K | — | 2026-06-24 | 2026-06-26 |
Anderson Kenneth Carl Director · Stock Option (Right to Buy) · 2026-06-24 | Grant | 62K | — | 2026-06-24 | 2026-06-26 |
Bessen Laura Director · Stock Option (Right to Buy) · 2026-06-24 | Grant | 62K | — | 2026-06-24 | 2026-06-26 |
Koppikar Utpal Director · Stock Option (Right to Buy) · 2026-06-24 | Grant | 62K | — | 2026-06-24 | 2026-06-26 |
SEC filings
EDGAR filings in CCCC · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.